[DPHARMA] QoQ TTM Result on 30-Sep-2012 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- -3.93%
YoY- -9.12%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 140,724 137,091 135,311 132,969 140,215 141,205 138,132 1.24%
PBT 39,354 35,384 35,297 34,133 35,468 35,723 34,729 8.70%
Tax -9,526 -9,378 -9,282 -7,787 -8,043 -8,233 -8,023 12.14%
NP 29,828 26,006 26,015 26,346 27,425 27,490 26,706 7.65%
-
NP to SH 29,828 26,006 26,015 26,346 27,425 27,490 26,706 7.65%
-
Tax Rate 24.21% 26.50% 26.30% 22.81% 22.68% 23.05% 23.10% -
Total Cost 110,896 111,085 109,296 106,623 112,790 113,715 111,426 -0.31%
-
Net Worth 187,404 176,143 169,359 167,991 162,310 170,824 163,776 9.40%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 20,128 19,431 19,431 18,318 24,980 24,987 24,987 -13.43%
Div Payout % 67.48% 74.72% 74.69% 69.53% 91.09% 90.90% 93.56% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 187,404 176,143 169,359 167,991 162,310 170,824 163,776 9.40%
NOSH 138,818 138,695 138,819 138,836 138,727 138,881 138,793 0.01%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 21.20% 18.97% 19.23% 19.81% 19.56% 19.47% 19.33% -
ROE 15.92% 14.76% 15.36% 15.68% 16.90% 16.09% 16.31% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 101.37 98.84 97.47 95.77 101.07 101.67 99.52 1.23%
EPS 21.49 18.75 18.74 18.98 19.77 19.79 19.24 7.65%
DPS 14.50 14.00 14.00 13.20 18.00 18.00 18.00 -13.43%
NAPS 1.35 1.27 1.22 1.21 1.17 1.23 1.18 9.39%
Adjusted Per Share Value based on latest NOSH - 138,836
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 14.63 14.25 14.07 13.82 14.58 14.68 14.36 1.25%
EPS 3.10 2.70 2.70 2.74 2.85 2.86 2.78 7.54%
DPS 2.09 2.02 2.02 1.90 2.60 2.60 2.60 -13.55%
NAPS 0.1948 0.1831 0.1761 0.1746 0.1687 0.1776 0.1703 9.38%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 2.38 2.23 2.13 2.36 2.23 2.40 2.02 -
P/RPS 2.35 2.26 2.19 2.46 2.21 2.36 2.03 10.26%
P/EPS 11.08 11.89 11.37 12.44 11.28 12.13 10.50 3.65%
EY 9.03 8.41 8.80 8.04 8.87 8.25 9.53 -3.53%
DY 6.09 6.28 6.57 5.59 8.07 7.50 8.91 -22.42%
P/NAPS 1.76 1.76 1.75 1.95 1.91 1.95 1.71 1.94%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 17/05/12 22/02/12 -
Price 2.44 2.51 2.17 2.28 2.38 2.38 2.12 -
P/RPS 2.41 2.54 2.23 2.38 2.35 2.34 2.13 8.59%
P/EPS 11.36 13.39 11.58 12.01 12.04 12.02 11.02 2.04%
EY 8.81 7.47 8.64 8.32 8.31 8.32 9.08 -1.99%
DY 5.94 5.58 6.45 5.79 7.56 7.56 8.49 -21.20%
P/NAPS 1.81 1.98 1.78 1.88 2.03 1.93 1.80 0.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment